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Diﬀuse Optical Tomography (DOT) is an optical imaging modality that has various clinical applications. However, the spatial
resolution and quantitative accuracy of DOT is poor due to strong photon scatting in biological tissue. Structural ap r i o r i
information from another high spatial resolution imaging modality such as Magnetic Resonance Imaging (MRI) has been
demonstrated to signiﬁcantly improve DOT accuracy. In addition, a contrast agent can be used to obtain diﬀerential absorption
images of the lesion by using dynamic contrast enhanced DOT (DCE-DOT). This produces a relative absorption map that consists
of subtracting a reconstructed baseline image from reconstructed images in which optical contrast is included. In this study, we
investigated and compared diﬀerent reconstruction methods and analysis approaches for regular endogenous DOT and DCE-
DOT with and without MR anatomical ap r i o r iinformation for arbitrarily-shaped objects. Our phantom and animal studies have
shown that superior image quality and higher accuracy can be achieved using DCE-DOT together with MR structural ap r i o r i
information. Hence, implementation of a combined MRI-DOT system to image ICG enhancement can potentially be a promising
tool for breast cancer imaging.
1.Introduction
Diﬀuse optical tomography (DOT) utilizes near infrared
(NIR)lighttoprobetissueopticalproperties,mainlyabsorp-
tionandscattering.DOThasshownpromiseinbreastcancer
characterization and neoadjuvant chemotherapy monitoring
based on spatially resolved tissue intrinsic physiological
parameters, such as total hemoglobin concentration, oxygen
saturation, and water concentration. For example, total he-
moglobin concentration of tumors was found to be two-
to four-fold greater in tumors due to the enhanced tumor
vasculature and blood supply. Meanwhile, the oxygen sat-
uration levels were shown to be reduced compared to the
normal tissue, due to the increased oxygen consumption by
rapidly diﬀerentiating and metabolically active tumor cells
[1–7]. Similarly, decreased total hemoglobin concentration
is observed in breast cancer patients who responded to
neoadjuvant chemotherapy treatment [1, 8–10].
Despite the success of preliminary clinical data, the
inverse problem of DOT is severely ill-posed due to strong
scattering of light by tissue, which leads to poor spatial
resolution and low quantitative accuracy [11, 12]. Mainly,
measurements on the boundary are not sensitive to the
optical property variation induced by a small lesion embed-
ded in a heterogeneous medium. Meanwhile, reconstructed
absorption images are very sensitive to measurement noise,
which results in signiﬁcant artifacts caused by experimen-
tal uncertainties. Such uncertainties include optical probe
coupling to the tissue surface, source-detector position
uncertainty, and errors in determining the tissue boundary
for proper modeling of light propagation. In addition
to these problems, optical properties of the tissue diﬀer
signiﬁcantly not only for diﬀerent individuals but also for
the same individual at a diﬀerent physiological stage [6].
Furthermore, the widely used diﬀusion equation is only
an approximated model to describe light propagation in2 International Journal of Biomedical Imaging
tissue. This can cause modeling mismatch in the presence
of a low scattering region, such as the bladder [13, 14].
To overcome these limitations, exogenous contrast agents
c a nb eu s e dt oo b t a i nd i ﬀerential absorption images of
the lesion using dynamic contrast-enhanced DOT (DCE-
DOT) [15–18]. In particular, the contrast agent used in this
study is Indocyanine green (ICG), an FDA-approved NIR
absorber with peak absorption of 785nm. By subtracting
reconstructedbaseline (precontrast)absorption images from
the subsequent ones after the ICG injection (postcontrast),
the relative absorption enhancement map is obtained. Both
pre- and post-contrast measurements are acquired under the
same conditions, and, hence, this method is only sensitive to
the change of the optical signal. As a result, artifacts due to
the modeling error, individual diﬀerence, and experimental
uncertainty are remedied by this diﬀerential approach [15,
19]. In addition to the enhanced detection of lesions, the
pharmacokinetics of ICG uptake can be a potential phys-
iological marker for identifying breast lesion malignancy
similar to the role of the MR exogenous contrast agent, Gd-
DTPA, in dynamic contrast-enhanced magnetic resonance
imaging (DCE-MRI).
Another major problem of DOT is its low quantitative
accuracy. Indeed, recovered optical properties for an inclu-
sion highly depend on the depth and size of the lesion.
This limitation cannot be overcome by using an exogenous
contrast agent alone as demonstrated with phantom studies
previously [18]. In order to improve the accuracy of DOT,
structural ap r i o r iinformation from another high spatial
resolution imaging modality, such as magnetic resonance
imaging (MRI) or X-ray computed tomography (XCT), has
been utilized to constrain and guide DOT reconstruction
[7, 20].
There are only a few DCE-DOT studies using ICG as
an exogenous contrast agent. Diﬀerent analysis methods and
systems are used for these studies. For instance, Cuccia et al.
used diﬀuse optical spectroscopy (DOS) to obtain the ICG
kinetics and showed diﬀerent kinetics for diﬀerent tumor
types with an animal model [17]. Intes et al. and Ntziachris-
tos et al. used continuous wave breast DOT systems and
showed diﬀerent kinetics for cancerous and normal breasts
[15, 16].Using ICG enhancement kinetic data obtained from
eight patients, Rinneberg et al. observed that the absorption
coeﬃcientnormalizedtothetissuetotalhemoglobinconcen-
tration did not diﬀer for the normal and cancerous breast
tissue during the wash-out phase [21]. Following this study,
Hagen et al. showed that invasive carcinomas retain ICG
ﬂuorescence signal after being largely cleared out from the
body, indicating the high permeability of malignant tumors
[22]. In all these studies, however, the number of cases
was small and hence there was no conclusion about which
reconstruction and analysis method was optimal for DCE-
DOT. Furthermore, all of them were stand-alone DOT sys-
tems that did not utilize high resolution anatomical ap r i o r i
information.Inthelastcoupleofyears,ourlabhasdeveloped
a combined MRI-DOT small animal imaging system [23].
Initial results have demonstrated tumor enhancement using
ICG [24]. In this study, we investigated and compared dif-
ferent reconstruction methods and analysis approaches for
regular endogenous DOT and DCE-DOT with and without
MR structural ap r i o r iinformation for arbitrarily shaped
objects. We ﬁrst compared the regular DOT and DCE-DOT
results for various target-to-background concentrations.
Eight realistic arbitrarily shaped phantoms were imaged and
analyzed to show that the sensitivity of regular DOT results
highly depends on the shape of the object, position of the
inclusion, and the object to background contrast. However,
the inclusion can be resolved in all eight cases even at the
lowestcontrastwithcontrast-enhancedDOT.Inaddition,we
intendedtolookforthebestDCE-DOTdataanalysismethod
in this study. We compared ﬁve diﬀerent reconstruction
methods and demonstrated that an accurate enhancement
curve can only be obtained with MR ap r i o r iinformation.
In addition to the phantom studies, an in vivo study was
also carried out. Fisher rats bearing the R3230 breast tumor
model were imaged by our combined DOT-MRI system.
To be able to monitor the enhancement kinetics of ICG,
time resolution of the DOT system has been increased to 16
seconds using a heterodyne detection technique [18, 24].
In summary, our phantom and animal studies have
shown that superior image quality and higher accuracy can
be achieved using DCE-DOT together with MR structural a
priori information. Hence, implementation of a combined
MRI-DOT system to image ICG enhancement can poten-
tially be a promising tool for breast cancer imaging.
2. Methods
2.1. Instrumentation. A hybrid MRI-DOT animal imaging
system has previously been developed in our lab. The
schematic diagram and picture of the optic interface are
showninFigure 1.Thesystemutilizeseightsourcesandeight
detectors in a fan-beam geometry. The detector and source
ﬁbers that were chosen for this system are 1mm step-index
and 62.5μm gradient-index ﬁbers, respectively. An 8 × 32
ﬁber optic switch (DiCon Fiberoptics, GP700) is used to
multiplex the laser diode outputs through the source ﬁbers.
The lasers are modulated at 100MHz, and photomultiplier
tubes (Hamamatsu R7400-20) are used at the multiple
detection sites. Output of each PMT is ampliﬁed by a 65dB
RF ampliﬁer and recorded simultaneously using an NI 4472
8-channel DAQ system, after downconversion of the signal
frequency to 1kHz. Finally, the data is postprocessed to
obtain 64-phase and 64-amplitude measurements.
The MRI setup consists of a 4T MR system with
a custom-designed birdcage type RF coil, which is built
into the DOT interface. The MR console is developed by
ISOL technology. Fiber optic cables are passed through a
waveguide from the RF-shielded MRI room to the control
room, where the DOT detection unit and data acquisition
hardware are located.
2.2. Forward and Inverse Models for Diﬀuse Optical Tomog-
raphy. The diﬀusion equation is used to model the lightInternational Journal of Biomedical Imaging 3
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Figure 1: The hybrid MRI-DOT system. (a) Schematic of the DOT system. The system utilizes 6 laser diodes (LD 1–6). Only LD2 (785nm)
is used for DCE-DOT studies. The lasers are modulated at 100MHz by the network analyzer. The optical signals are collected by detector
ﬁbers prior to transmission to the detection system, which uses PMTs as detectors. After downconverting to 1kHz, signals are recorded
simultaneously by a data acquisition card (DAQ). (b) The ﬁber optic interface. Eight sources and eight detectors are placed in fan-beam
geometry. A 16-leg birdcage RF coil is integrated into the interface. When placed in the MRI bore, both optical and MR measurements can
be acquired simultaneously.
propagation in tissue [12]. In the frequency domain, it can
be written as
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where the Φ(r,ω) is the ﬂuence rate. D(r)( m m −1)d e n o t e s
thediﬀusioncoeﬃcient,whichisdeﬁnedbyD = 1/3(μa+μ 
s).
The reduced scattering and the absorption coeﬃcients of
the medium are represented as μ 
s (mm−1)a n dμa (mm−1),
respectively. The modulation angular frequency and the
speed of light in the tissue are represented by ω and cn,
respectively.
TheRobinboundaryconditionrelatestheopticalﬂuence
rate to optical ﬂux at the boundary and can be written as
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where n is the direction perpendicular to the boundary.
A is the boundary mismatch parameter that accounts for
the light reﬂection on the boundary surface, which is
determined by Fresnel reﬂections [25]. Hence, the photon
ﬂux measurement on the boundary is
φ =− D
 − → r
 ∂Φ
∂n
=
Φ
2A
. (3)
A point source q0(r,ω) = δ(r − rs) is used in this
simulation. The extrapolated boundary condition is applied
to model the position of the source [25]. For each source
position, eight measurements are obtained at the detector
sites. Therefore, a total of 64-amplitude and 64-phase data
are obtained from the forward solver. The diﬀusion equation
is solved with the ﬁnite element method (FEM). The details
have been described previously [26, 27].
The inverse problem is solved by minimizing the diﬀer-
ence between the measured and calculated data according to
the following error function:
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Here, irepresentsthenumberofsourcesand j representsthe
number of detectors. φm
ij is the measurement. Pij(μa) is the
ﬂux on the measured point calculated by the forward solver
from the spatial distribution of μa. We iteratively update the
unknown μa with the Levenberg-Marquardt method by
Xm+1 = Xm +
 
JTJ +λI
 −1 
JTε
 
,( 5 )
whereεij = (φm
ij−Pij)a n dX represents the unknown matrix
of μa. The dimension of X is N. N represents the number of
nodes in the FEM mesh. The Jacobian matrix J is calculated
with the adjoint method [12].
When structural ap r i o r iinformation is utilized dur-
ing the reconstruction process, “Laplacian-type ap r i o r i ”
developed by Yalavarthy et al. is implemented to ﬁnd the
absorption coeﬃcient for the inclusion [28]. The L-matrix
can be written as
Lij =
⎧
⎪ ⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎪ ⎩
0i f i and j are not in the same region,
1
Nr
if i and j are in the same region,
1i f i = j,
(6)
where Nr represents the number of nodes included in one
region. Then, the update equation can be expressed as
Xm+1 = Xm +
 
JTJ +λLTL
 −1 
JTε
 
. (7)4 International Journal of Biomedical Imaging
Whenthesourceanddetectorcoupling is considered,the
coupling coeﬃcientis explicitly recoveredasunknowns from
the measurements. This has been described by Boas et al.
previously [29, 30]. The modiﬁed measurements are
Φi,j = si ×dj ×ΦForward
i,j ,( 8 )
wheresi and dj are the coupling factors for the ith source and
jth detector position.
For each arbitrarily shaped phantom, a ﬁnite element
mesh is generated from the MR image. In order to reduce
the computational cost, the dual mesh strategy is used. The
following steps were followed during the mesh generation
procedure.
(1) MR and optical image coregistration: the center of
the RF coil and optical probes are determined from
the MR image by using ﬁducial markers. As shown
in Figure 2(a), the center is determined using two
orthogonal markers manually.
(2) XCT image segmentation: the MR image is segmented
based on the signal intensity. A binary mask is
generated by setting a threshold to exclude all the
pixels with lower than half of the maximum intensity
(Figure 2(b)).
(3) Boundary delineation: the exterior boundary pixels of
the binary mask are extracted. The number of points
is then reduced by choosing one of every ﬁve pixels.
This reduced set is used to generate a ﬁnite element
mesh (Figure 2(c)).
(4) Source and detector position mapping: as the last step,
the source and detector positions are mapped to
the coordinates on the mesh manually by placing
sixteen lines separated by 22.5 degrees as shown in
Figure 2(d).
2.3. Phantom Studies. Eight arbitrarily shaped phantoms
were constructed to test several diﬀerent analysis meth-
ods. The phantoms were prepared using agarose powder
(OmniPur Agarose, Lawrence, KS). Intralipid and Indian ink
were added as the optical scattering and absorbing media,
respectively. 10mm inner-diameter thin-walled NMR tubes
ﬁlled with a dye and Intralipid mixture were inserted at
diﬀerent depths as the inclusions. The optical properties of
the homogeneous background were set to μa = 0.01mm−1
and μ 
s = 0.6mm −1. The shape of the phantoms and the
location of the inclusions are determined from the MR
images. For each phantom, inclusions with ﬁve diﬀerent
object-to-background contrast (OBC) values were prepared
and designated by B0, B2, B4, B6, and B8 (OBC: 1, 2,
4, 6, and 8) that corresponded to μa = 0.01, 0.02, 0.04,
0.06,and0.08mm−1,r espectiv ely .Theabsorptionmapswer e
reconstructed individually at each time point. For the DCE-
DOT, enhancement images were produced by subtracting
preinjection from postinjection reconstructed images. From
the set of ﬁve diﬀerent OBC values, B2 through B8 were
selected as the postinjection frames, while B0 was assumed
as the preinjection (baseline) frame.
A complete set of data was also acquired using a
homogeneous DOT calibration phantom at the end of each
case. This was a solid cylindrical homogeneous phantom
madeofepoxy.TheopticalpropertiesoftheDOTcalibration
phantom were set to μa = 0.006mm−1 and μ 
s = 1.0mm −1.
Later, the experimental data (Fmeasured) was calibrated using
the homogeneous phantom measurements (Fhomo measured)
Fcalibrated =
Fmeasured
Fhomo measured
×Fhomo forw,( 9 )
where Fhomo forw was calculated by the forward solver. The
calibrated data Fhete calibrated was then fed into the inverse
solver. This step took into account for the data/model
mismatch.
2.4. Data Analysis. Our ﬁrst aim is to investigate the
eﬀectiveness of the contrast-enhanced DOT compared to
regular DOT. A variety of irregularly shaped phantom data
allow us to evaluate the modeling mismatch as well as
other factors such as optical probe coupling to the tissue
surface, source-detector position uncertainty, and errors in
delineating medium boundary from the MR images. Our
second aim is to investigate whether implementing the
decoupling technique or reconstructing absorption images
alone instead of together with scattering images can alleviate
some of these problems. Above those, our ﬁnal aim to
examine the inﬂuence of the structural ap r i o r iinformation
on the accuracy of DCE-DOT. To address these questions,
four methods are used to analyze the experimental data.
Method No. 1. Both 64-amplitude and 64-phase data are
used to simultaneously reconstruct both absorption and
scattering maps. The selection of the ROI for calculating
the absorption coeﬃcient is determined by full width half
maximum (FWHM) of the inclusion in the DCE-DOT map.
Method No. 2. Only 64-amplitude data are used to recon-
struct absorption maps. The scattering coeﬃcient of the
phantom is assumed to be homogeneous and obtained by
ﬁtting a homogeneous absorption and scattering value to
both amplitude and phase measurements. The selection of
the ROI was determined by FWHM of the inclusion resolved
in the DCE-DOT map. Most optical contrast agents intro-
duce only signiﬁcant absorption change. For this method,
the equivalent continuous wave analysis is performed to
investigate if continuous wave domain measurements are
suﬃcient for DCE-DOT experiments.
Method No. 3. Only 64-amplitude data are used to recon-
struct absorption maps. The scattering coeﬃcient of the
phantom is also assumed to be homogeneous as in Method
no. 2. Afterwards, the DOT reconstruction performed here
takes into account the source-detector coupling factors. The
selectionoftheROIisdeterminedbyFWHMoftheinclusion
resolved in the DCE-DOT map.
Method No. 4. MR structural ap r i o r iinformation is used in
this approach. The ROI is predeﬁned from the MR image.International Journal of Biomedical Imaging 5
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Figure 2: Finite element mesh generation from MR image. (a) Selection of the center points based on the ﬁducial markers. (b) A binary
mask is generated representing the shape of the phantom from the MR image. (c) Finite element mesh is generated according to the exterior
boundary obtained from the binary mask for optical data analysis. (d) Source and detector positions are then determined.
Afterwards, the DOT reconstruction is performed using the
structural ap r i o r iinformation described earlier in Section 2.
The ROI is already determined from MRI as the structural a
priori.
2.5. In Vivo Study. To further validate the hybrid system
and our analysis methods, animal studies were carried out.
All animal procedures were approved by the Institutional
Animal Care and Use Committee at University of California,
Irvine. Fischer rats subcutaneously implanted with R3230
adenocarcinoma breast tumor were used for this study. The
R3230 cell line is a lactating mammary tumor model that
has been previously characterized as a breast cancer model
[31].Thecellswereallowedtogrowuntiltheresultingtumor
reached a size of approximately 1cm, when the DCE-DOT
studies were performed.
The FDA-approved optical contrast agent ICG was used
in this study. A 785nm laser was used to perform the
DCE-DOT study, which corresponds to the peak absorption
of ICG. 32 frames of DOT measurements were obtained
throughout each experiment with 16-second temporal res-
olution. ICG was injected during the 7th frame as a single
bolus together with the MR contrast agent Gd-DTPA. The in
vivo data was also analyzed using two diﬀerent methods.
Method No. 1. Only 64-amplitude data were used to recon-
struct absorption maps. The scattering maps were assumed
to be homogeneous (μ 
s = 0.8mm −1), which was obtained
by ﬁtting the maps to both amplitude and phase data. The
selection of the ROI was determined by the FWHM of the
inclusion resolved in the peak DCE-DOT map. This was
similar to Method no. 2 in the phantom study.
Method No. 2. MR structural ap r i o r iinformation was used
in this approach. The ROI was predeﬁned from the MR
image. Then the DOT reconstruction was performed using
the structural ap r i o r iinformation. This was similar to
Method no. 4 in the phantom study.
3. Results
Initially, reconstruction results are compared using only
Method no. 1 for two diﬀerent contrast values, B2 and B8,
to show the eﬀectiveness of DCE-DOT. While absorption
maps are reconstructed individually at each time point for
both regular DOT and DCE-DOT, enhancement images are
produced by subtracting the B0 image from the B2 and B8
images for all eight DCE-DOT phantom cases. During the
comparison, the main criteria are the ability of resolving6 International Journal of Biomedical Imaging
the inclusion and the reduction of artifacts in the images.
After that, diﬀerent methods such as reconstruction of μa
onlyusing64-amplitudedata(no.2),thedecouplingmethod
(no. 3) and utilization of MR structural ap r i o r iinformation
(no. 4) are compared utilizing only the highest contrast,
B8 (OBC: 8). Finally, the errors in the recovered mean
absorption values are compared for all four methods. This
step is repeated for each contrast value for all eight cases.
The recovered values as well as the diﬀerence between the
recovered values and the expected values are also plotted.
3.1. Comparison between DCE-DOT and Regular DOT.
The results are shown in Figure 3. The MR image of each
phantom is listed in the ﬁrst column. Data analysis Method
no. 1 is used for the DOT reconstruction, where both phase
and amplitude are used to reconstruct both the absorption
and scattering maps. The reconstructed regular DOT and
DCE-DOT absorption maps for the low contrast, B2 (OBC:
2), are shown in the second and third columns, respectively.
Similarly, the reconstructed maps for the high contrast,
B8 (OBC: 8), are shown in the fourth and ﬁfth columns.
When the contrast is low, regular DOT cannot resolve the
inclusions conﬁdently for all cases, and the images are also
signiﬁcantly contaminated by the background artifacts.
For instance, the inclusions can be resolved in Cases 3,
5, and 7, even though many artifacts are present. At the
same time, they cannot even be localized in all the other
cases (Figure 3-column two). When the contrast increases
to eight, however, inclusions are clearly identiﬁed for all
cases (Figure 3-column four). If DCE-DOT is utilized, on
the other hand, they are clearly resolved for all of the cases,
even if the OBC is as small as two (Figure 3-column three).
As expected, the quality improves further when the contrast
increases to eight (Figure 3-column ﬁve).
These initial results demonstrate the superiority of the
DCE-DOT method, that is the reconstructed images signif-
icantly improved from columns two to three. The artifacts
in the background are also signiﬁcantly diminished. The
results show that it is very diﬃcult forregularDOTto resolve
small objects in an arbitrarily shaped medium. The model
might fail due to the insensitivity of small perturbations
in a heterogeneous medium. However, DOT can be very
sensitive to the increase of absorption in the inclusion (e.g.,
administration of contrast agent), and, hence, it can be easily
localized with DCE-DOT.
3.2. Comparison between Diﬀerent DCE-DOT Reconstruction
Methods. In this section, we intend to address the eﬀective-
ness of other methods described in Section 2.4. The results
are shown in Figure 4. Respectively, the ﬁrst and second
columns are the reconstructed regular DOT and DCE-DOT
absorption maps for the highest contrast, B8, using analysis
Method no. 2 (reconstructing μa only). Similarly, the third
and fourth columns present the reconstructed maps using
analysis Method no. 3 (accounting for the coupling factor),
while the ﬁfth and sixth columns show the reconstructed
maps using analysis Method no. 4 (with MR ap r i o r i
information).
3.2.1. Reconstruction of Both μa and μ 
s versus Reconstruction
of μa Only. The results of the reconstruction of both μa and
μ 
s are presented in the fourth and ﬁfth columns in Figure 3
(Section 3.1), while the results of the reconstruction of the
μa-onlyapproachisshownintheﬁrstandsecondcolumnsof
Figure 4. For the regular DOT reconstruction, the inclusions
are resolved with fewer artifacts when both μa and μ 
s are
simultaneously reconstructed. Apparently, the error in the
scattering coeﬃcient aﬀects the reconstructed results if μa is
reconstructed by itself. For instance, the inclusions are not
visible for Cases 1, 3, and 4 in Figure 4-column one.
This demonstrates the limitation of a continuous wave
technique, which cannot eﬀectively separate scattering and
the absorption coeﬃcients. These eﬀects are expected to
be more severe for in vivo situations, where tissue is more
heterogeneous. Despite this issue, the DCE-DOT images for
both methods, μa and μ 
s or μa only, clearly resolve the inclu-
sions in all of the cases. The enhancement absorption images
produced in DCE-DOT are only sensitive to the absorption
variation due to the contrast agent. Hence, even though
therearemodelingandexperimentalerrorsineachframefor
the μa-only reconstruction, the resulting enhancement maps
consistently resolve each inclusion for each case.
3.2.2. Reconstruction with versus without Source-Detector
Decoupling. The reconstruction results with and without
source-detector coupling are shown in Figure 4.A se x p e c t e d ,
the hypersensitivity at the source-detector positions is sig-
niﬁcantly reduced if the coupling factor is considered. This
validates the importance of taking into account the coupling
factor during regular DOT studies. Similar to the previous
method, the recovered images using DCE-DOT using both
methods are comparably good. Meanwhile, it should be
noted that the contrast is reduced when the source-detector
coupling factor is considered. Fang et al. also reported this
phenomenon previously [7]. Indeed, the coupling factor
decreases the object-to-background contrast. In summary,
the source-detector decoupling method improves the regular
DOT reconstruction results but decreases the recovered
contrast for both regular DOT and DCE-DOT.
3.2.3. Reconstruction with versus without MR A Priori Infor-
mation. The reconstruction results utilizing MR ap r i o r iin-
formation are shown in the ﬁfth and sixth columns in
Figure 4. Signiﬁcant improvement is obtained when MR a
priori information is utilized. For regular DOT, the recovered
absorption for the inclusion is strongly enhanced by the
anatomical constraint. As expected, the DCE-MRI results
shown in the sixth column are clearly without artifacts in
the background. These results conclude that the absorption
inclusion can be consistently recovered when the MRI
anatomical information is used.
3.3. Comparison among Diﬀerent DCE-DOT Analysis Meth-
ods. Recovering accurate enhancement kinetics of a contrast
agent using DCE-DOT necessitates a linear relationship be-
tween the signal variation and the concentration of agent.
Accordingly, we test the linearity of the recovered absorptionInternational Journal of Biomedical Imaging 7
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Figure 3: Comparison between regular DOT and DCE-DOT. Column 1: MR images of all the phantoms. Columns 2 and 4: regular
endogenous DOT reconstruction for the contrasts B2 and B8, respectively. At B2 contrast, regular DOT cannot resolve the inclusion
accurately, and the images are also contaminated by the background noise signiﬁcantly. Even though all of the inclusions can be located
when contrast is high, artifacts are still present in the regular DOT image. Columns 3 and 5: DCE-DOT reconstruction for contrast B2
(B2–B0) and B8 (B8–B2), respectively. The inclusions are clearly identiﬁed for both low and high contrast. This shows the superiority of
DCE-DOT.
coeﬃcient of the inclusion for each case at the ﬁnal step.
For each analysis method described in Section 2.4 (Table 1)
a linear ﬁt was performed as shown in Figure 5. The red
dashed line represents the linear ﬁt to the data points in
each graph. The red bar graph represents the deviation of
the data from the linear ﬁt. As seen from the ﬁgure, there
is a comparatively large deviation from the linear ﬁt without
MR spatial ap r i o r i ,regardless of the optical reconstruction8 International Journal of Biomedical Imaging
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Figure 4: Comparison among diﬀerent methods of reconstruction for the absorption coeﬃcient, μa (m−1), please note that unit of m−1 is
used for display purposes. The ﬁrst and second columns present the reconstructed regular DOT and DCE-DOT absorption maps for B8
using analysis Method no. 2 (reconstructing μa only). The third and fourth columns show the reconstructed maps using analysis Method no.
3 (taking the source-detector coupling factor into account), while the ﬁfth and sixth columns are for the reconstructed maps using analysis
Method no. 4 (MR ap r i o r iinformation is used). When the source-detector coupling factor is considered, the hypersensitivity at the source-
detector positions due to coupling errors is reduced. Furthermore, when MRI ap r i o r iinformation is utilized, the inclusion can be clearly
identiﬁed without background artifacts.
method. In contrast, this nonlinearity is remedied by using
MR ap r i o r iinformation, as shown in the fourth column in
Figure 5, where the diﬀerence between the ﬁt and the actual
data is much smaller.
To show the eﬀect of this nonlinearity on the recovered
enhancement curve, Case no. 1 data was used for further
analysis. For this purpose, a synthetic enhancement kinetics
curve is created using all ﬁve data points. The true curve
is shown as the solid blue line in Figure 4.T h er e c o v -
ered enhancement kinetics with and without MR ap r i o r i
information (Methods no. 3 and no. 5) are shown as the
green and red lines, respectively. The recovered absorption
increase is more accurate when MRI information is utilized
(Figure 6(a)). In general, the normalized kinetics is oftenInternational Journal of Biomedical Imaging 9
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Table 1: The summary of ﬁve analysis methods for phantom studies.
Method N o .1 N o .2 N o .3 N o .4
64 A+Φ 64 amplitude + 64 phase 64 A+Φ 64 A 64 A 64 A
64 A 64 amplitude
μa +μs
  both μa and μ 
s reconstructed μa +μ 
s μa μa μa
μa only μa is reconstructed
Decoup Decoupling technique is used — — Decoup —
DOT ROI is obtained from DOT DOT DOT DOT MRI
MR ROI is obtained from MRI
MR priori MR structural ap r i o r iis used — — — MR ap r i o r i
05 1 0
0
0.02
0.04
0.06
0.08
True
Without MRI
Simulated time points
Δ
µ
s
(
m
m
−
1
)
With MRI
(a)
05 1 0
0
0.5
1
True
Without MRI
Simulated time points
Δ
µ
s
(
m
m
−
1
)
With MRI
(b)
Figure 6: Enhancement kinetics curve analysis of the ﬁrst case. The solid blue line represents the true value of the inclusion’s optical
properties, while the red and green lines represent the recovered values with and without MR ap r i o r iinformation. Each point on the
graph is taken from a diﬀerent concentration phantom case (B0, B2, etc.) and is organized in this way to simulate a synthetic enhancement
curve.
used in DCE analysis. Accordingly, the normalized kinetics
curve is plotted in Figure 6(b). The recovered enhancement
curve matches to the true synthetic curve only when the
optical reconstruction is guided and constrained using MR
information. These results conﬁrm that the best way to
analyze DCE-DOT data is to utilize structural ap r i o r iinfor-
mation.
3.4. In Vivo Study. The anatomic T1-weighted MR image
of the rat is shown in Figure 7(a). The tumor region is
indicated with the yellow circle. The size of the tumor is
approximately 1.5cm. in diameter. First, DOT and DCE-
DOT are compared for their ability to resolve the tumor. For
this purpose the reconstructed peak DOT absorption map is
compared with the diﬀerence image (DCE-DOT) obtained
by subtracting the baseline image from the peak DOT
absorption map. This step is also repeated without and with
MR ap ri o riinformation. The peak reconstructed absorption
maps without and with MRI anatomical information are
shown in Figures 7(a) and 7(c), respectively. The DCE-DOT
diﬀerence maps at the peak absorption without and with
MRI are also shown in Figures 7(b) and 7(d). The tumor
region is visible and clearly shows higher absorption in DOT
images. Still, there are several hot spots present in the image
as well. However, the artifacts are signiﬁcantly suppressed on
DCE-DOT diﬀerential maps. Meanwhile, both regular DOT
and DCE-DOT diﬀerential maps are improved when MRI
anatomicalaprioriinformationofthetumorlocationisused
for the DOT reconstruction.
In addition to this, the ICG enhancement kinetics
curve is also produced with and without MR ap r i o r i .
Figure 7(e) shows the kinetics of the absolute absorption
change, while Figure 7(f) shows the normalized kinetics with
respect to the maximum value. The increase in absorption
coeﬃcients is considerably underestimated without MR a
priori information. Furthermore, the normalized kinetics isInternational Journal of Biomedical Imaging 11
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Figure 7: Results from an in vivo study using Fischer rats for both regular and dynamic contrast enhancement DOT. (a) shows the T1 image
of the rat at the slice that DOT data were acquired. (b) and (d) show the peak reconstructed DOT maps without and with MRI ap r i o r i
information, respectively. (c) and (e) show the DCE-DOT diﬀerential maps without and with ap r i o r iinformation (i.e., the baseline map is
subtracted from the peak absorption map). Finally, (f) shows the dynamic enhancement curves using the recovered absorption coeﬃcient
in the ROI. (g) displays the normalized DCE curves with respect to the maximum value.
separated during the wash-out phase. This is in agreement
withourphantomresults,inwhichtheenhancementkinetics
deviated without MRI ap r i o r iinformation. In conclusion,
the utilization of MRI ap r i o r iinformation for in vivo DCE-
DOT study is demonstrated to be functional.
4. Conclusion and Discussion
In this paper, we investigate various analysis methods for
DCE-DOT. The signiﬁcance of this study is threefold. First,
the DCE-DOT data is obtained using a hybrid MRI-DOT
system. Therefore, the utilization of anatomical ap r i o r i
information for DCE-DOT can be investigated. This is the
ﬁrst time anatomical ap r i o r iinformation from another
high spatial resolution imaging modality is applied in
DCE-DOT analysis. Second, various DOT reconstruction
methods are investigated in realistic arbitrarily shaped agar
phantoms. Regular shaped phantoms such as cylindered or
slab phantoms are used in most previous phantom studies.
However,theshapeofthephantomaﬀectsthereconstruction
signiﬁcantly due to the modeling mismatch, thus eight
phantoms are used in our study to have a wide range of12 International Journal of Biomedical Imaging
geometries. The quantitative accuracy of the recovered DCE-
DOT enhancement curves is compared among several analy-
sismethods.WeconcludedthatDCE-DOTwithMRIapriori
informationprovidesthebestenhancementimagesandmost
accurate enhancement kinetics. Finally, we investigated an in
vivocase. In vivo results agree with the phantom studies. The
diﬀerence in the enhancement kinetics obtained without and
with MR structural ap r i o r iwas not drastic as in the case of
phantom studies, presumably due to the close proximity of
the tumor to the boundary.
In this study, we showed that the high-absorption area
enhanced by exogenous contrast is consistently localized
by the DCE-DOT technique without many background
artifacts. The results suggest that DCE-DOT can reliably
resolve a lesion. However, it is worth noting that DCE-DOT
and regular DOT provide essentially diﬀerent physiological
parameters. For example, multiwavelength DOT provides
total hemoglobin concentration, oxygen saturation, and
other optical markers for cancer imaging. This information
cannot be obtained by DCE-DOT, though higher enhance-
ment might correlate well with total hemoglobin contents.
On the other hand, DCE-DOT has the potential to provide
additional tumor information about morphological vascular
diﬀerences from the enhancement kinetics [15, 16]. Due to
this reason, it is important to obtain an accurate kinetics
curve. Unlike DCE-MRI, DCE-DOT does not have high
spatial resolution. As a result, the recovered enhancement
kinetics depends on the analysis technique and choice of
the ROI. We demonstrated in this paper that accurate ICG
kinetics can only be recovered with MR spatial ap r i o r i
information.
ICG pharmacokinetics have been investigated previously
and found to be diﬀerent between healthy and diseased
tissues [16]. However, the focus of this paper is to evaluate
the best way to acquire accurate ICG kinetics. Thus, pharma-
cokinetic analysis is not performed. As the next step, more in
vivo data are being acquired to evaluate if ICG kinetics can
be used for tumor diagnosis and therapy monitoring.
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